Ritivixibat

DB18030InvestigationalSmall molecule

Ritivixibat: Overview.

Chemical structure of Ritivixibat
Formula / weight
C26H36N2O5S2 · 520.7 g/mol (avg)
Also known as
3-([3,3-dibutyl-7-(methylsulfanyl)-1,1-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-1Lambda6,2,5-benzothiadiazepin-8-yl]oxy)propanoic acid

Resolves to

Compound
UNII3U7H6NE2KECAS2460667-52-9
Structure
InChIKeyXHOVXESPVIUTMC-UHFFFAOYSA-NSMILESCCCCC1(CCCC)CN(C2=CC=CC=C2)C2=CC(SC)=C(OCCC(O)=O)C=C2S(=O)(=O)N1

What you can answer from here — as of April 02, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Ritivixibat, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In